{
  "id": 12892893,
  "title": "FDA Says Its Safety Review of Abortion Pill Will Continue Into Next Year",
  "url": "https://urgent.news/2026/10/08/fda-says-its-safety-review-of-abortion-pill-will-continue-into-next-12892893",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-08T13:22:22.000Z",
  "source": {
    "name": "MedPage Today",
    "slug": "medpage-today",
    "url": "https://www.medpagetoday.com/washington-watch/fdageneral/123314"
  },
  "original_language": "en",
  "account": null,
  "summary": "(MedPage Today) -- The FDA says its ongoing safety review of mifepristone, the nation's main abortion pill, will continue into next year, a timeline that was quickly condemned by abortion opponents hoping to see the drug's use curtailed. The FDA...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "STAT News",
        "title": "FDA says its safety review of abortion pill will continue into next year",
        "url": "https://urgent.news/2026/10/08/fda-says-its-safety-review-of-abortion-pill-will-continue-into-next-12896827",
        "published": "2026-10-08T15:02:53.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}